| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/03/1991 | EP0419576A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 04/03/1991 | EP0380508A4 Improved protein c molecules and method for making and activating same |
| 04/03/1991 | CA2026618A1 Insect neuropeptides |
| 04/02/1991 | US5004818 Mixing nonionic surfactant with EDTA-salt solution for precipitation from tissues gives improved yields |
| 04/02/1991 | US5004803 Recombinant dna coding for factor VIII in which its B domain is replaced with a peptide sequence of factor V |
| 04/02/1991 | US5004694 Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal antibodies |
| 04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
| 04/02/1991 | US5004688 Purification of hepatitis proteins |
| 04/02/1991 | US5004686 Process for producing human epidermal growth factor and analogs thereof |
| 04/02/1991 | CA1282360C Animal cell culture |
| 03/31/1991 | CA2026468A1 Human endothelin-3 cdna and use thereof |
| 03/30/1991 | WO1991005055A1 Method for the preparation of an immunizing composition |
| 03/30/1991 | CA2067172A1 Process for preparing an immunizing composition |
| 03/30/1991 | CA2025487A1 Hplc avidin monomer affinity resin |
| 03/27/1991 | EP0419292A1 Human tryptase-like protein |
| 03/27/1991 | EP0419238A1 Antibodies and proteins |
| 03/27/1991 | EP0419182A1 New HCV isolates |
| 03/27/1991 | EP0419099A1 Proteins having anticoagulant properties |
| 03/27/1991 | EP0419091A1 Interleukin-4 receptors |
| 03/27/1991 | EP0418827A1 Vaccine against Lyme disease |
| 03/27/1991 | EP0418626A2 Fused proteins and production thereof |
| 03/27/1991 | EP0418590A1 Antibodies, production thereof and use |
| 03/27/1991 | EP0418347A1 Human monoclonal antibodies to human immunodeficiency virus |
| 03/27/1991 | EP0418316A1 Platelet-specific chimeric immunoglobulin |
| 03/27/1991 | EP0418283A1 Antibodies |
| 03/27/1991 | EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity. |
| 03/27/1991 | EP0209586B1 Anti-histamine antibody preparation with specificity for a 4-(2-aminoethyl)imidazolyl group attached directly to an alkylene chain and immunoassay method employing the preparation |
| 03/27/1991 | CA2026122A1 Monoclonal antibody against an acidic fgf protein, its production and use |
| 03/26/1991 | WO1991004274A1 Method for inhibiting growth of stem cells |
| 03/26/1991 | US5003048 Solvent extraction to isolate lymphokines used as antitumor agents |
| 03/26/1991 | US5003046 Monoclonal antibody producing hybridoma and corresponding antibody specific for human breast fibroblast tumor antigen |
| 03/26/1991 | US5002888 Bacillus; air pollution control |
| 03/26/1991 | US5002878 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses |
| 03/26/1991 | US5002877 Production of plasminogen activator from cells to which lectin is added to the culture medium |
| 03/26/1991 | US5002876 Pichia pastoris culture |
| 03/26/1991 | US5002871 Enzymatic membrane method for the synthesis and separation of peptides |
| 03/26/1991 | US5002869 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes |
| 03/26/1991 | CA2025960A1 Methods for modulating promoter responsible for beta amyloid precursor protein expression |
| 03/26/1991 | CA1282022C Method for purifying an interferon |
| 03/26/1991 | CA1282021C Particulates having the immunogenic power of the hbs antigen and carrying an antigenic site foreign to the epitopes carried by the hbs antigen; vectors and animal cells for the production of such particulates and compositions containing such particulates for the production of mixed vaccines |
| 03/24/1991 | WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 03/24/1991 | CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 03/24/1991 | CA2025942A1 Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays |
| 03/23/1991 | WO1991004273A2 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
| 03/23/1991 | CA2066607A1 Peptides associated with the cd4 binding region of gp120 and their methods of use |
| 03/23/1991 | CA2025630A1 Human tryptase-like protein |
| 03/21/1991 | WO1991004329A1 Method of producing fusion proteins |
| 03/21/1991 | WO1991003569A1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
| 03/21/1991 | WO1991003557A1 Expression of alpha-macroglobulins |
| 03/21/1991 | WO1991003556A1 Recombinant product |
| 03/21/1991 | WO1991003552A1 Recombinant negative strand rna virus expression systems and vaccines |
| 03/21/1991 | WO1991003550A1 Fusion proteins, their preparation and use |
| 03/21/1991 | WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 03/21/1991 | WO1991003162A1 Chimeric dna-rna catalytic sequences |
| 03/21/1991 | WO1991002080A3 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 03/21/1991 | CA2025684A1 Antibodies and proteins |
| 03/20/1991 | WO1991004336A1 Method for improving human monoclonal antibody production |
| 03/20/1991 | EP0417906A1 Expression of a functional insect specific toxin gene in mammalian cells |
| 03/20/1991 | EP0417563A2 TNF-binding proteins |
| 03/20/1991 | EP0417524A1 Antigens and polypeptides derived from babesia (12D3 antigen) |
| 03/20/1991 | EP0417486A1 Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| 03/20/1991 | EP0417196A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |
| 03/20/1991 | EP0417168A1 Antibodies to human mammary cell growth inhibitor and methods of production and use |
| 03/20/1991 | EP0172865B1 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 03/20/1991 | CA2066720A1 Method for improving human monoclonal antibody production |
| 03/20/1991 | CA2025481A1 Vaccine for aids and hepatitis b |
| 03/19/1991 | US5001230 T cell activation markers |
| 03/19/1991 | US5001112 Antitumor antibiotic kedarcidin |
| 03/19/1991 | US5001065 Human cell line and triomas, antibodies, and transformants derived therefrom |
| 03/19/1991 | US5001057 Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins |
| 03/19/1991 | US5001056 Linking proliferating cells and B-cells through antigens and surface immunoglobulins, fusing |
| 03/19/1991 | US5001052 Immunoassay for FHAP and antibody useful therewith |
| 03/19/1991 | US5000953 Biologically active substance |
| 03/19/1991 | CA2025577A1 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
| 03/19/1991 | CA1281849C Solubilization of protein aggregates |
| 03/19/1991 | CA1281671C Enhanced yeast transcription employing hybrid promoter region constructs |
| 03/19/1991 | CA1281646C Recombinant interleukin-2 composition and process for making it |
| 03/16/1991 | WO1991004316A2 Ciliary neurotrophic factor |
| 03/16/1991 | WO1991004262A1 New hcv isolates |
| 03/16/1991 | CA2040404A1 Ciliary neurotrophic factor |
| 03/14/1991 | CA2025230A1 Treponema hyodysenteriae antigens having a molecular weight of 39 kda and dna encoding therefor |
| 03/13/1991 | WO1991004320A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 03/13/1991 | EP0416673A1 Method for the expression of heterologous proteins produced in fused form in E. coli, use thereof, expression vectors and recombinant strains |
| 03/13/1991 | EP0416652A2 Interferon-gamma receptor fragment and its production |
| 03/13/1991 | EP0416578A2 Protein, DNA and use thereof |
| 03/13/1991 | EP0416505A2 Expression plasmids and use thereof |
| 03/13/1991 | EP0416029A1 Procalcitonin peptides |
| 03/13/1991 | EP0415930A1 T cell activation markers |
| 03/13/1991 | EP0415929A1 Heteroligating antibodies and therapeutic uses thereof |
| 03/13/1991 | EP0415919A1 NEW TOXIN-ENCODING DNA FRAGMENTS FROM $i(BACILLUS) $i(THURINGIENSIS) SUBSP. $i(ISRAELENSIS) |
| 03/13/1991 | EP0403554A4 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
| 03/13/1991 | CN1049866A Efficient production of mutant proteases |
| 03/13/1991 | CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
| 03/12/1991 | WO1991004267A1 A method for the purification of transforming growth factor (tgf-) |
| 03/12/1991 | WO1991003551A1 Production of growth hormone in transgenic animal milk |
| 03/12/1991 | US4999349 BU-4164E - A and B, prolyl endopeptidase inhibitors |
| 03/12/1991 | US4999291 Production of human pluripotent granulocyte colony-stimulating factor |
| 03/12/1991 | US4998799 Stereoscope |
| 03/12/1991 | CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions |
| 03/12/1991 | CA2065866A1 Production of growth hormone in transgenic animal milk |